Title: Nancy Ng - Innovator in Targeted Drug Delivery
Introduction
Nancy Ng is a notable inventor based in Vaughan, Canada. She has made significant contributions to the field of bioconjugation, particularly in the targeted delivery of anti-viral compounds. Her innovative approach aims to enhance the efficacy of treatments for viral infections.
Latest Patents
Nancy Ng holds a patent titled "Targeted Delivery Of Anti-Viral Compounds Through Hemoglobin Bioconjugation." This invention focuses on the targeted delivery of anti-viral compounds through protein bioconjugation. More specifically, it involves an anti-viral compound conjugated to hemoglobin and outlines a method for treating viral infections using this conjugate. The invention also provides a method for targeted drug delivery of an anti-viral nucleoside analogue to macrophages and cells that express a hemoglobin receptor, as well as to CD163 bearing cells.
Career Highlights
Nancy Ng is currently associated with Therapure Biopharma Inc., where she continues to work on innovative solutions in biopharmaceuticals. Her research and development efforts are aimed at improving therapeutic strategies for viral infections.
Collaborations
Nancy has collaborated with notable colleagues, including Gordon J Adamson and David N Bell, who contribute to her research endeavors and the advancement of her projects.
Conclusion
Nancy Ng is a pioneering inventor whose work in targeted drug delivery has the potential to significantly impact the treatment of viral infections. Her innovative methods and collaborations highlight her commitment to advancing biopharmaceutical research.